---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-002132"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2023-01-23T23:59:59+00:00"
generated_at: "2026-06-20T11:46:26.313247+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Panacea Life Sciences signs LOI to acquire N7 Enterprises for 22.2M shares

## Summary
- Panacea will issue 22.2 million common shares to N7 Enterprises stockholders.
- N7 Enterprises had $4.1M revenue in FY2022 and estimated net income exceeding $1M.
- Expected close on or around February 28, 2023, subject to due diligence and definitive agreement.
- N7 operates Florida kava/kratom lounges (Lizard Juice, N7 Nitro Kava) and a distribution subsidiary.

## SEC filing metadata
- accession: 0001493152-23-002132
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2023-01-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315223002132/0001493152-23-002132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315223002132/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-002132
- JSON: https://secwatch.observer/filing/0001493152-23-002132.json
- Plain text: https://secwatch.observer/filing/0001493152-23-002132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.